J-GLOBAL ID:201801007247727283   Update date: Aug. 31, 2020

Takeshi Tomita

Takeshi Tomita
Affiliation and department:
Papers (37):
  • Tomita T, Ieguchi K, Deguchi A, Takita M, Tsukahara F, Hiratsuka S, Maru Y. Lung Tumor Cell Recruitment Assay. Journal of visualized experiments : JoVE. 2019. 144
  • Yokoyama S, Cai Y, Murata M, Tomita T, Yoneda M, Xu L, Pilon AL, Cachau RE, Kimura S. A novel pathway of LPS uptake through syndecan-1 leading to pyroptotic cell death. eLife. 2018. 7
  • Tomita T, Ieguchi K, Takita M, Tsukahara F, Yamada M, Egly JM, Maru Y. C1D is not directly involved in the repair of UV-damaged DNA but protects cells from oxidative stress by regulating gene expressions in human cell lines. The journal of biochemistry. 2018
  • Sachie Hiratsuka, Takeshi Tomita, Taishi Mishima, Yuta Matsunaga, Tsutomu Omori, Sachie Ishibashi, Satoshi Yamaguchi, Tsuyoshi Hosogane, Hiroshi Watarai, Miyuki Omori-Miyake, et al. Hepato-entrained B220+CD11c+NK1.1+ cells regulate pre-metastatic niche formation in the lung. EMBO molecular medicine. 2018. 10. 7
  • A. Deguchi, T. Tomita, U. Ohto, K. Takemura, A. Kitao, S. Akashi-Takamura, K. Miyake, Y. Maru. Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment. ONCOGENE. 2016. 35. 11. 1445-1456
MISC (5):
  • TLR4/MD-2 ligands promote metastasis. Thrombosis Medicine. 2018. 8. 2. 117-121
  • 富田 毅, 丸 義朗. 肺がんへの転移とS100A8. 生体の科学. 2016. 67. 5. 460-461
  • 富田 毅, 丸 義朗. TLR4/MD-2の蛋白質内因性リガンドと癌転移の分子基盤. 医学のあゆみ. 2015. 253. 11. 1099-1103
  • 富田 毅, 丸 義朗. 臓器連関とがん転移前土壌形成. 細胞工学. 2014. 33. 5. 508-511
  • 富田 毅, 齋藤正男. 最近のヘムタンパク質研究. 生化学. 2003. 75. 5. 577-587
Professional career (1):
  • 博士(理学) (総合研究大学院大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page